AstraZeneca agrees to supply Europe with 400 million doses of COVID-19 vaccine
Published
AstraZeneca Plc has signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker's latest deal to pledge its drug to help combat the pandemic.
Full Article